Abstract 18882: Efficacy and Safety of Rivaroxaban in Patients with Peripheral Artery Disease: A GRADE-Assessed Systematic Review and Meta-Analysis
Background: Peripheral artery disease (PAD) is a progressive atherosclerotic condition associated with high cardiovascular and limb-related morbidity. Despite guideline-recommended antiplatelet therapy, patients with PAD remain at substantial residual risk of ischemic and limb events. Rivaroxaban, a direct Factor Xa...